MedInvest Oncology 
Investor Conference

June 28-29, 2022

TAKING PLACE
June 28-29, 2022
One Vanderbilt Avenue
McDermott Will & Emery, 67th Floor
New York, NY 10017

2 Days Presentations, Panels, and Keynotes
3 Days 1-on-1 Meetings

Access the 
Partnering System

100+ Investors
40+ Presenting Companies
6-8 Keynotes and Panels
CEO Workshops
Partnering System
One-on-One Meetings

ABOUT THE MEDINVEST ONCOLOGY INVESTOR CONFERENCE 

The upcoming semiannual meeting of the MedInvest Oncology Investor Conference Series will be held on June 28-29, 2022. The event will take place in New York City at One Vanderbilt Avenue, and will be streamed to remote audience, mainly comprised of investors outside of New York and nearby cities.

The conference will feature two days of company presentations, panel discussions, and keynote talks. Both in-person and virtual meetings will be taking place during the two days of the conference. Virtual meetings will continue for one more day. The partnering system will be open for communications for one full month.

The presenting companies are developing and/or commercializing a broad spectrum of technologies, including those in Biotech, Pharmaceuticals, Diagnostics, Medical Device and Equipment, AI/Data Analytics, Precision Medicine, and others.

The event is the preeminent indication specific investor conference. The attendees are active investors in the oncology space and oncology-focused companies seeking investment.  The meetings of the Oncology Investor Conference have been held twice a year since 2017.

​

The National Cancer Institute and McDermott Will & Emery Law Firm are the Presenting Partners. Oncology Investor Conference Series sponsors include Perkins Coie, Cooley Law Firm, Venable Law Firm, Freemind Consultants, Torreya Partners and Marcum.

Join the leading life science and oncology venture capitalists, family offices, lawyers, pharma executives, private and public cancer companies and foundations for a discussion on trends, opportunities, and risks in oncology investing.